广州安必平医药科技股份有限公司股东减持股份结果公告

Summary of Key Points Core Viewpoint - The announcement details the results of a share reduction plan executed by major shareholders of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd., indicating a complete execution of the planned share reduction. Group 1: Shareholder Holdings - Prior to the reduction plan, shareholders including Zhuhai Gaotejia Ruian Investment Partnership and its concerted actions held a total of 6,292,662 shares, representing 6.7253% of the company's total equity [2]. Group 2: Implementation of Reduction Plan - On November 6, 2025, the company disclosed a share reduction plan allowing the aforementioned shareholders to reduce their holdings by up to 935,676 shares, which is 1.00% of the total equity [3]. - The shareholders successfully reduced their holdings by exactly 935,676 shares, meeting the planned reduction target [3]. - The reduction was conducted in compliance with relevant laws and regulations, and there were no violations of the reduction plan or other commitments [3].